Phase 1 N=20 Finasteride 5 mg Tablets, Non-fasting
Healthy
Primary: Cmax - Maximum Observed Concentration — 33.037; 32.242 ng/mL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=30 Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions
Healthy
Primary: Cmax = Maximum Observed Concentration. — 295; 256 ng/mL
Phase 1 N=24 Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions
Healthy
Primary: Cmax = Maximum Observed Concentration. — 311.45; 382.48 ng/mL
Phase 1 N=40 Granisetron 1 mg Tablets Under Fasting Conditions
Healthy
Primary: Cmax (Maximum Observed Concentration) — 10.7738; 11.0935 ng/mL
Phase 1 N=24 Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions
Healthy
Primary: Cmax (Maximum Observed Concentration) — 53.89; 55.19 µg/mL
Phase 1 N=22 Levetiracetam 750 mg Tablets Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 21.625; 23.501 mcg/mL
Phase 1 N=24 Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions
Healthy
Primary: Cmax (Maximum Observed Concentration) — 14802.55; 14808.74 pg/mL
Phase 1 N=22 Levetiracetam 750 mg Tablets Under Non-Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 19.635; 20.054 mcg/mL
Phase 1 N=32 Lamotrigine 25 mg Chewable Tablets, Non-Fasting
Healthy
Primary: Cmax - Maximum Observed Concentration — 612.45; 604.85 ng/mL
Phase 1 N=14 The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects
Healthy
Primary: Dasatinib Pharmacokinetic (PK) Parameter: Maximum Observed Plasma Concentration (Cmax) — 65.58; 38.64 ng/mL
Phase 1 N=103 Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)
Type 2 Diabetes
Primary: 24-hour Weighted Mean Glucose (WMG) — 169.1; 159.0; 200.9 mg/dL — p=0.004
Phase 1 N=26 Cefprozil for Oral Suspension 250 mg/5 mL, Fasting
Healthy
Primary: Cmax (Maximum Observed Concentration) — 5.924; 6.508 ng/mL
Phase 1 N=36 Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 28.79; 28.95 ng/mL
Phase 1 N=38 Cefprozil 500 mg Tablets Under Fasting Conditions
Healthy
Primary: Cmax (Maximum Observed Concentration) — 11.509; 11.573 ng/mL
Phase 1 N=40 Mycophenolate Mofetil Tablets Under Fed Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 7.4578; 8.2195 µg/mL